Cargando…
Test–Retest Reliability of the Impact of Vision Impairment–Very Low Vision Questionnaire
PURPOSE: Most patient-reported outcome measures used in ophthalmology show floor effects in a very low vision population, which limits their use in vision restoration trials. The Impact of Vision Impairment–Very Low Vision scale (IVI–VLV) was developed to specifically target a very low vision popula...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266551/ https://www.ncbi.nlm.nih.gov/pubmed/37306995 http://dx.doi.org/10.1167/tvst.12.6.6 |
Sumario: | PURPOSE: Most patient-reported outcome measures used in ophthalmology show floor effects in a very low vision population, which limits their use in vision restoration trials. The Impact of Vision Impairment–Very Low Vision scale (IVI–VLV) was developed to specifically target a very low vision population, but its test–retest reliability has not been investigated yet. METHODS: The German version of the IVI–VLV was administered twice to patients with stable disease of a low vision clinic. Test and retest person measures of the IVI–VLV subscales were obtained from Rasch analysis. Test–retest reliability was investigated by intraclass correlation coefficients and Bland–Altman plots. RESULTS: We included 134 patients (72 women, 62 men) at a mean age of 62 ± 15 years. The intraclass correlation coefficients were 0.920 (95% confidence interval, 0.888–0.944) for the activities of daily living and mobility subscale of the IVI–VLV and 0.929 (95% confidence interval, 0.899–0.949) for the emotional well-being subscale. Bland–Altman plots did not indicate any systematic bias. In linear regression analysis, test–retest differences were not significantly associated with visual acuity or administration interval. CONCLUSIONS: Both subscales of the IVI–VLV showed excellent repeatability independent of visual acuity and length of repeat interval. Further validation steps including an assessment of the patient-reported outcome measure's responsiveness are required for use in vision restoration trials. TRANSLATIONAL RELEVANCE: The results support repeated use of the IVI–VLV as a patient-reported end point in future studies in very low and ultralow vision populations. |
---|